Beam Therapeutics Inc. (BEAM) Return On Equity % [USD] 2019 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Beam Therapeutics Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2024.
  • Beam Therapeutics Inc. Return On Equity for the quarter ending March 31, 2024 was -15.5 %, a 63.2% increase year-over-year.
  • Beam Therapeutics Inc. annual Return On Equity for 2023 was -15.9 %, a 57.7% increase from 2022.
  • Beam Therapeutics Inc. annual Return On Equity for 2022 was -37.6 %, a 32.8% increase from 2021.
  • Beam Therapeutics Inc. annual Return On Equity for 2021 was -55.9 %, a 32.6% increase from 2020.
Return On Equity, Quarterly (% [USD])
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -15.5 +26.6 +63.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -15.9 +21.7 +57.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 -40.7 -0.86 -2.16% Jul 1, 2023 Sep 30, 2023
Q2 2023 -43.3 -15 -53.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -42 -10.9 -34.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -37.6 +18.3 +32.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 -39.8 +37.8 +48.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -28.3 +86.9 +75.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -31.2 +102 +76.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 -55.9 +27.1 +32.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -77.6 +25.9 +25% Jul 1, 2021 Sep 30, 2021
Q2 2021 -115 +260 +69.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 -133 -278 -192% Jan 1, 2021 Mar 31, 2021
Q4 2020 -83 -131 -274% Oct 1, 2020 Dec 31, 2020
Q3 2020 -103 Jul 1, 2020 Sep 30, 2020
Q2 2020 -375 Apr 1, 2020 Jun 30, 2020
Q1 2020 144 Jan 1, 2020 Mar 31, 2020
Q4 2019 47.6 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.